ISSN 1662-4009 (online)

ey0021.4-9 | New Mechanisms | ESPEYB21

4.9. Reduction in pappalysin-2 levels and lower IGF-I bioavailability in female adolescents with anorexia nervosa

V Barrios , A Martin-Rivada , S Guerra-Cantera , A Campillo-Calatayud , RA Camarneiro , M Graell , JA Chowen , J Argente

Brief Summary: This study investigated the effects of anorexia nervosa (AN) on the insulin-like growth factor (IGF) axis in female adolescents. It evaluated levels of various proteins and their role in the IGF axis, including pregnancy-associated plasma protein A2 (PAPP-A2) and stanniocalcins (STC-1 and STC-2). The reduced levels of PAPP-A2 may impair IGFBP cleavage, thereby reducing IGF-I bioavailability. IGF1 plays a crucial role in regulating growth, metabolism, and bone he...

ey0015.2-18 | Dietary composition, age, and sex determine the central inflammatory response associated with the long-term outcomes of excess weight gain | ESPEYB15

Dietary composition, age, and sex determine the central inflammatory response associated with the long-term outcomes of excess weight gain

P Argente-Arizón , F Díaz , P Ros , V Barrios , M Tena-Sempere , LM García-Segura , J Argente , JA Chowen

To read the full abstract: Endocrinology. 2018 Jan 1;159(1):368-387Hypothalamic inflammation has been linked to the development and progression of obesity and its sequelae. Obesity in rodents and humans is associated with gliosis of the arcuate nucleus, a key hypothalamic region for the regulation of energy homeostasis and adiposity. Gliosis, the activation of astrocyte and microglial cell popula...

ey0020.2-12 | New Perspectives | ESPEYB20

2.12. Pappalysins and stanniocalcins and their relationship with the peripheral IGF axis in newborns and during development

A Martin-Rivada , S Guerra-Cantera , A Campillo-Calatayud , EM Andres-Esteban , M Sanchez Holgado , GA Martos-Moreno , J Pozo , M Guemes , L Soriano-Guillen , A Pellicer , C Oxvig , J Frystyk , JA Chowen , V Barrios , J Argente

Brief summary: Growth Hormone (GH)-Insulin-Growth-Factor-1 (IGF-1) axis plays the major role in promoting growth, but novel factors seem to modulate GH-IGF1 axis functioning. The majority of circulating IGF-1 and IGF-2 are bound to IGF-binding proteins (IGF-BPs) which prolong their half-life and regulate their tissue distribution (1,2). Pappalysins (PAPP-A, PAPP-A2) increase IGF-1 bioavailability through cleavage of IGFBPs and are inhibited by stanniocalcins (STC1, STC2) (3,4)...